| Revenue growth | Q2 +35.94%, H1 +30.96% YoY |
|---|---|
| Margins | Q2 PBT margin ~3.2% (computed); H1 PBT +95.43% |
| Demand visibility | Growing specialized ophthalmic demand cited; not quantified |
Growth
H1 PBT ₹156.89 lakh, up 95.43%. H1 expenses ₹33.72 Cr, up 28.62%, below revenue growth.
Outlook
No numeric guidance. Qualitative plans: new hospitals and satellite centres, technology upgrades, phased expansion; capex not quantified.
Risks
No explicit headwinds disclosed. Cash only ₹1.74 Cr against ₹17.73 Cr borrowings; lease liabilities excluded from borrowings.
Investor Presentation filed with BSE, NSE: LOTUSEYE. Summary written with AI assistance from the document.
Lotus Eye Hospital and Institute Ltd: key numbers
- Share price
- ₹101.12
- Market cap
- ₹210.3 Cr
- Revenue (annual)
- ₹53.71 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 444.6×Sector 64.9×
- Promoter holding
- 40.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lotus Eye Hospital and Institute Ltd
All →Lotus Eye Hospital and Institute Promoter Buying (Off-Market)
Promoter shares were transmitted by inheritance to three family members after a promoter's death. Combined promoter holding rises to about 40%, with no market purchase.
Lotus Eye Hospital and Institute Other Announcement
Lotus Eye Hospital transmitted 5,01,837 shares of deceased promoter Dr. Sundaramoorthy to three existing promoters. The aggregate promoter group holding remains unchanged.
Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital has issued a postal ballot notice seeking member approval to raise its borrowing limit and charge limit to Rs 100 Crore each. Remote e-voting runs from 20 November to 19 December 2026.
Lotus Eye Hospital and Institute Results Update
Lotus Eye Hospital reported Q2 FY27 revenue of ₹17.72 crore, up 36%, with net profit of ₹43.95 lakh. Half-year net profit rose 59% to ₹1.05 crore.
Lotus Eye Hospital and Institute Q2 FY27 Results: Net Profit ₹0.4 Cr, Up 300.0% YoY
Lotus Eye Hospital approved unaudited quarterly results for September 2026. Quarter net profit was Rs.43.95 lakhs on revenue of Rs.1,772.41 lakhs.
- Key figure
- Net profit ₹0.4 Cr · +300.0% YoY
Lotus Eye Hospital and Institute Board Meeting Date
Lotus Eye Hospital intimated that its Board meeting is scheduled for 11/11/2026 to consider unaudited Q2/H1 results. The trading window will reopen after results declaration.